No definition available.
Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)
C3_CML_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
319 |
4. Check minimum number of eventsNone |
319 |
5. Include endpointsNone |
319 |
6. Filter based on genotype QC (FinnGen only) |
319 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 319 | 145 | 174 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.08 |
| Median age at first event (years) | 58.32 | 57.50 | 59.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 142
- Matched controls
- 1419
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
202.0
141
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3516.3
175.5
135
7
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
164.2
124
*
189
Kela drug reimbursment
Imatinib
+∞
131.5
105
*
L01XE01
ATC
[U] imatinib; oral
+∞
105.9
88
*
XW000
NOMESCO Finland
Bone marrow biopsy
88.6
70.6
76
18
M04AA01
ATC
allopurinol; systemic
26.6
61.2
98
109
L01XX05
ATC
hydroxycarbamide; oral
156.4
56.9
57
6
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
51.2
46
*
316
Kela drug reimbursment
Imatinib
+∞
46.4
42
*
152
Kela drug reimbursment
Nilotinib
+∞
39.4
36
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
119.2
34.6
36
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
33.7
31
*
L01XX28
ATC
[D] imatinib; oral
+∞
33.7
31
*
150
Kela drug reimbursment
Dasatinib
+∞
28.0
26
*
L01XE08
ATC
[U] nilotinib; oral
+∞
28.0
26
*
L03AA02
ATC
filgrastim; parenteral
+∞
25.8
24
*
212
Kela drug reimbursment
Gout
51.4
24.7
29
7
L01XE06
ATC
[U] dasatinib; systemic
+∞
24.7
23
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
22.5
21
*
328
Kela drug reimbursment
Nilotinib
+∞
20.3
19
*
L01EA03
ATC
nilotinib; oral
+∞
20.3
19
*
127
Kela drug reimbursment
Transplant complication
42.9
18.2
22
6
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
18.1
17
*
L01EA02
ATC
dasatinib; oral
+∞
18.1
17
*
324
Kela drug reimbursment
Dasatinib
+∞
18.1
17
*
A05AA02
ATC
ursodeoxycholic acid; oral
51.3
12.1
14
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
38.5
11.5
14
*
L04AA01
ATC
[U] ciclosporin; systemic
27.7
11.4
15
6
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
118.3
10.6
11
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
10.5
10
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
43.4
10.1
12
*
WW500
NOMESCO Finland
Blood transfusion
14.8
9.9
16
12
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
59.1
9.8
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
9.5
9
*
L03AA04
ATC
NA
+∞
9.5
9
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
9.5
9
*
R50.9
ICD-10 Finland
Fever, unspecified
4.2
9.4
38
113
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
39.4
9.2
11
*
WW200
NOMESCO Finland
Immunization
11.8
9.0
16
15
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
95.4
8.5
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
8.4
74
388
170
Kela drug reimbursment
Bosutinib
+∞
8.4
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
+∞
8.4
8
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
8.4
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
7.8
22
44
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
7.7
31
91
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
84.2
7.5
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
7.3
7
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.8
7.3
20
39
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
6.9
38
143
C03CA01
ATC
furosemide; systemic
2.8
6.8
55
265
A03FA01
ATC
metoclopramide; systemic, rectal
3.9
6.5
27
81
A01AB04
ATC
amphotericin B; local oral
6.3
6.4
16
28
B73
ICPC
Leukaemia
+∞
6.3
6
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
6.3
6
*
J05AB11
ATC
valaciclovir; oral
3.7
6.2
27
85
B99
ICD-10 Finland
Other and unspecified infectious diseases
13.3
6.2
10
8
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.7
6.1
20
48
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
6.0
49
233
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
92
22
58.36
158.35
1.5
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
97
33
41.80
152.03
2.5
2.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
146
219
11.45
102.79
4.5
2.3
e9/l
68.2
67.3
0.09
111
173
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
89
0
+∞
98.10
15.7
0.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
87
0
+∞
95.76
11.7
0.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
163
302
9.99
95.57
5.4
2.1
%
1.8
1.7
0.37
157
274
(3017181) Myelocytes/100 leukocytes in Blood
117
175
9.98
80.80
9.0
4.2
%
2.7
0.7
4.91
61
41
(3002179) Metamyelocytes/100 leukocytes in Blood
102
159
8.96
67.12
8.7
4.4
%
1.6
0.3
4.00
39
32
(42870588) Differential panel, method unspecified - Blood
217
748
6.95
63.61
20.5
5.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
41
18
25.99
57.22
1.3
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
93
168
7.40
52.73
10.4
4.3
%
0.4
0.1
2.70
58
37
(3001604) Monocytes [#/volume] in Blood
261
1202
7.44
51.35
20.3
5.0
e9/l
0.6
0.6
0.63
252
1048
(3025159) Blasts/100 leukocytes in Blood
89
159
7.38
50.87
9.7
4.4
%
1.3
2.5
0.18
44
35
(3006315) Basophils [#/volume] in Blood
261
1208
7.38
50.87
20.4
5.0
e9/l
0.0
0.0
0.22
251
1055
(3019198) Lymphocytes [#/volume] in Blood
262
1232
7.31
49.65
20.5
5.0
e9/l
2.0
1.9
0.36
253
1087
(3005719) IgG [Mass/volume] in Serum or Plasma
91
171
7.05
49.46
2.3
2.1
g/l
8.8
11.1
5.98
85
157
(3013115) Eosinophils [#/volume] in Blood
263
1249
7.30
49.02
22.2
5.2
e9/l
0.2
0.2
0.64
255
1106
(3026493) Urate [Moles/volume] in Serum or Plasma
185
679
5.11
46.55
6.7
2.3
umol/l
341.0
8643.8
3.57
177
599
(3013650) Neutrophils [#/volume] in Blood by Automated count
267
1347
7.03
44.49
29.3
6.2
e9/l
3.6
4.3
4.18
257
1187
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
60
100
7.16
35.98
1.8
2.0
g/l
1.3
1.4
0.68
53
87
(3028026) IgM [Mass/volume] in Serum or Plasma
70
139
6.17
35.29
1.3
1.4
g/l
1.1
1.1
0.02
65
129
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
37
11.52
34.90
1.2
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
232
1180
4.54
34.31
14.9
5.4
mmol/l
1.2
1.2
0.43
204
1017
(40760892) CBC W Ordered Manual Differential panel - Blood
144
531
4.12
33.70
15.1
4.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
66
132
6.04
32.91
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
33
11.79
32.78
1.1
1.2
u/ml
138.3
110.4
—
9
5
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
36
10.80
30.88
2.5
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
163
687
3.81
30.80
11.3
3.1
ph
7.4
7.4
0.72
31
106
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
53
8.73
30.49
1.7
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
35
39
9.96
29.13
2.3
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
210
1071
3.81
29.12
13.4
4.7
mmol/l
1.2
1.2
0.18
202
956
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
28
25
12.18
27.04
2.3
1.9
pg
33.6
34.1
0.19
28
25
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
96
306
4.06
26.79
3.2
2.4
%
22.8
23.2
0.12
83
265
(44790048)
24
17
15.18
26.49
1.6
1.4
—
—
—
0
0
(44806118)
24
17
15.18
26.49
1.6
1.4
—
—
—
0
0
(44790049)
24
17
15.18
26.49
1.6
1.4
—
—
—
0
0
(44790047)
24
17
15.18
26.49
1.6
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
36
9.43
24.94
6.6
3.8
%
53.2
58.1
0.94
31
36
(4035726)
38
58
7.30
24.41
1.5
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
12
17.71
23.92
4.1
2.0
e6/l
726.7
835.4
—
7
5
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
22
11.72
22.70
10.9
3.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
137
606
3.21
22.43
6.9
3.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
35
8.67
21.22
6.5
3.3
e9/l
3.0
4.5
2.32
28
35
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
27
9.96
21.14
2.5
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
18
12.42
20.66
8.3
2.7
%
46.8
50.3
0.15
13
12
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
16
13.27
20.50
2.2
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
16
13.27
20.50
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
123
542
3.07
19.84
21.7
4.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
123
552
3.00
19.08
7.4
3.2
%
90.7
89.9
0.12
117
544
(3021589) Normoblasts [#/volume] in Blood
187
1054
2.87
18.84
26.8
7.8
e9/l
0.0
0.0
0.72
172
864
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
91
362
3.12
17.24
2.8
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
76
276
3.30
16.73
1.6
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
134
669
2.73
16.56
5.7
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
43
6.77
16.56
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
5
42.53
16.53
4.1
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
13
12.90
16.14
4.4
2.4
e9/l
0.9
0.8
—
10
7
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
23
9.21
16.06
1.6
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
124
603
2.73
16.05
2.8
2.1
mg/l
2.8
3.0
0.36
114
510
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
149
797
2.63
15.88
3.3
2.3
u/l
58.0
57.6
0.05
144
734
(3013826) Glucose [Moles/volume] in Serum or Plasma
225
1475
2.78
15.69
8.4
4.0
mmol/l
6.8
6.7
0.04
219
1371
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
39
6.87
15.61
1.1
1.2
u/ml
352.1
232.6
0.95
19
22
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
33
7.43
15.47
1.8
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
66
237
3.25
14.68
1.6
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
174
1034
2.50
14.45
8.5
3.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
65
5.17
14.34
1.1
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
172
1024
2.47
14.13
4.3
2.6
ug/l
264.0
131.5
3.30
166
945
(3048879) Bone marrow aspiration report
18
6
31.65
14.03
2.9
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
166
978
2.45
13.88
6.9
8.6
inr
1.2
1.3
0.81
45
260
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
151
3.65
13.80
1.8
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
150
853
2.43
13.46
4.3
3.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
20
8.92
13.37
2.6
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
67
256
3.05
13.34
2.5
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
26
7.71
13.26
2.0
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
36
6.49
13.11
1.0
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
67
261
2.98
12.87
2.4
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
16
9.79
12.64
2.8
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
16
9.79
12.64
2.8
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
16
9.79
12.64
2.8
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
12
11.25
12.03
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
24
7.43
11.53
2.6
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
32
83
4.17
11.41
2.6
1.7
ug/l
1.9
2.1
0.06
32
76
(3004588) Protein electrophoresis panel - Serum or Plasma
48
165
3.25
11.34
1.3
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
63
4.59
10.99
1.7
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
43
5.42
10.95
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
55
4.85
10.91
1.4
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
77
4.20
10.84
2.4
3.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
23
7.27
10.67
1.9
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
131
760
2.23
10.62
6.7
2.0
mmol/l
2.3
2.4
2.41
125
634
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
18
8.09
10.22
1.9
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
39
5.40
9.97
1.1
1.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
135
812
2.15
9.82
6.6
2.8
u/l
39.7
33.5
0.44
129
769
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
11
10.32
9.59
1.6
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
11
10.32
9.59
1.6
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
166
2.99
9.40
3.0
2.6
e9/l
7.4
3.9
0.61
38
122
(40760888) Immunoglobulin light chains.free panel - Serum
19
38
5.25
9.21
1.4
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
24
6.51
9.07
2.0
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
18
7.49
8.91
3.2
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
10
10
10.29
8.68
1.7
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
22
6.61
8.60
1.6
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
16
7.75
8.47
1.8
1.1
e6/l
20620.5
20495.3
—
6
10
(3007164) IgA [Mass/volume] in Serum or Plasma
88
470
2.20
8.45
1.5
1.3
g/l
2.1
2.7
3.68
69
276
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
23
6.32
8.25
1.1
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
5
22.70
8.07
3.5
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
93
518
2.12
7.98
6.0
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
119
728
2.01
7.91
2.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
70
351
2.27
7.78
1.7
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
69
344
2.28
7.77
2.0
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
17
37
4.80
7.49
1.0
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
93
536
2.04
7.19
1.9
1.7
mg/l
1.6
1.0
1.06
76
406
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
44
4.28
6.91
1.9
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
40
4.43
6.84
2.2
2.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
57
277
2.29
6.77
9.5
5.7
kpa
12.2
11.6
0.48
52
267
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
21
59
3.74
6.71
1.4
1.3
—
1.1
—
0
6
(3012441) Differential panel - Pleural fluid
11
18
6.29
6.47
1.5
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
56
277
2.24
6.37
9.6
5.7
mmol/l
1.1
1.6
0.31
39
218
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
22
5.63
6.33
1.0
1.0
—
—
—
0
0
(4212803)
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
87
514
1.95
6.17
1.8
1.8
nmol/l
1253.1
1159.2
0.41
81
391
(3021960) Folate [Moles/volume] in Serum or Plasma
102
636
1.89
6.15
1.9
1.5
nmol/l
20.2
21.3
0.30
93
543
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
8
12.85
6.12
1.8
3.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
112
722
1.85
6.07
4.8
2.9
e6/l
28.7
154.5
0.76
97
546
(3007853) Bacteria identified in Skin by Aerobe culture
58
299
2.15
5.94
2.1
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
159
2.50
5.75
3.7
3.6
mmol/l
0.3
2.0
1.34
25
114
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
25
4.95
5.54
1.7
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
34
144
2.52
5.45
1.9
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
5
16.35
5.43
3.6
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
5
16.35
5.43
3.8
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
5
16.35
5.43
3.8
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
5
16.35
5.43
1.4
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
38
170
2.40
5.42
1.3
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
9
8
11.53
5.32
6.6
1.4
e9/l
0.2
0.2
—
9
8
(3035880) pH of Pleural fluid
9
8
11.53
5.32
1.4
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
9
10.25
5.05
3.6
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
9
10.25
5.05
3.6
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
9
10.25
5.05
3.6
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
9
10.25
5.05
3.6
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
82
509
1.82
4.88
3.2
2.2
e6/l
5.0
4.6
0.10
77
434
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
7
11.68
4.81
1.3
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
7
11.68
4.81
1.3
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
97
639
1.74
4.71
4.5
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
89
572
1.77
4.70
1.6
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
30
129
2.46
4.67
1.6
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
5
14.27
4.59
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
5
14.27
4.59
7.6
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
7
5
14.27
4.59
1.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
95
2.65
4.41
1.4
1.2
g/l
8.4
10.5
2.08
16
80
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
148
1107
1.63
4.37
2.3
2.0
pmol/l
92.1
95.2
0.32
103
555
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
96
2.62
4.32
1.5
1.3
g/l
3.3
3.1
0.46
15
74
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
56
3.15
4.31
2.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
229
1914
1.70
4.30
6.1
4.0
mm/h
14.1
11.4
1.95
222
1756
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
6
11.89
4.29
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
6
11.89
4.29
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
137
1009
1.63
4.28
3.7
3.6
ng/l
24.6
75.9
0.86
111
712
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
51
3.25
4.27
1.8
2.1
g/l
129.4
132.5
—
10
36
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
103
2.55
4.25
1.5
1.3
g/l
7.1
7.5
0.37
15
77
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
103
2.55
4.25
1.5
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
103
2.55
4.25
1.5
1.3
g/l
3.6
3.8
0.38
15
73
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
150
2.26
4.13
1.7
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
51
287
1.92
4.08
2.0
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
98
672
1.66
4.02
4.6
2.8
e6/l
0.6
0.4
0.22
86
488
(3014576) Chloride [Moles/volume] in Serum or Plasma
53
304
1.89
4.01
13.8
5.0
mmol/l
104.0
104.2
0.05
53
297
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
447
1.76
3.97
4.2
2.0
mmol/l
2.4
2.4
0.11
71
382
(3018095) Leukocytes [#/volume] in Urine
117
843
1.61
3.93
5.5
3.4
e6/l
87.0
91.8
0.04
103
592
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
39
3.43
3.80
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
5
12.19
3.77
1.5
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
16
5.75
3.68
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
86
2.54
3.63
3.6
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
43
238
1.93
3.61
5.5
3.2
mmol/l
2.5
2.3
0.10
35
194
(3012544) pH of Venous blood
44
250
1.88
3.42
5.5
3.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
34
177
2.03
3.39
4.0
4.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
10
7.13
3.38
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
65
2.71
3.36
4.7
2.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
60
378
1.72
3.33
4.7
2.8
e6/l
2.3
2.6
0.14
39
193
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
60
2.75
3.28
1.6
1.3
ug/g
237.1
323.9
—
9
36
(40761535) Cells panel - Urine sediment
39
216
1.92
3.28
2.8
3.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
38
3.24
3.24
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
38
3.24
3.24
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
68
2.58
3.09
2.9
2.2
u/ml
0.3
0.4
0.10
12
32
(3028433) Virus identified in Specimen by Culture
6
8
7.62
3.06
1.0
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
54
338
1.72
3.06
1.3
1.4
titre
349.1
491.6
0.40
11
79
(3045788) Cell count panel - Pleural fluid
7
12
5.94
3.03
1.9
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
12
5.94
3.03
1.4
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
12
40
3.08
3.00
3.0
3.1
mmol/l
3.0
2.7
—
6
20
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
35
3.22
2.96
2.5
2.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
201
1705
1.48
2.88
5.2
4.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
23
110
2.18
2.86
4.4
4.1
mmol/l
24.3
25.0
0.39
23
104
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
36
3.13
2.83
1.1
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
36
3.13
2.83
1.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
84
2.34
2.83
2.3
1.5
—
—
—
0
0
(3019225) pH of Specimen
39
229
1.80
2.75
7.9
3.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
11
37
3.04
2.72
1.4
2.4
u/l
59331.6
6730.4
—
5
14
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
10
6.09
2.71
6.8
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
209
1802
1.46
2.64
5.4
3.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
130
2.00
2.53
4.5
3.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
150
1223
1.43
2.53
3.8
3.6
estimate
0.0
0.0
0.00
25
196
(3021901) Oxygen saturation in Capillary blood
12
45
2.73
2.48
2.3
2.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
40
2.81
2.40
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
52
2.56
2.39
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
33
195
1.77
2.30
16.2
6.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
147
1209
1.40
2.29
5.0
4.9
estimate
0.0
0.0
0.00
30
200
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
29
3.16
2.24
1.3
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
24
3.39
2.19
1.1
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
31
183
1.77
2.17
4.0
3.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
19
3.74
2.16
1.4
1.1
—
—
—
0
0
(3010421) pH of Blood
12
49
2.51
2.13
3.0
3.4
ph
7.4
7.4
0.06
12
39
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
10
5.06
2.08
1.0
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
274
2539
1.56
2.05
36.9
12.0
mg/l
19.7
23.0
0.90
250
1936
(3017704) Immunofixation for Urine
6
15
4.06
2.05
1.5
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
15
4.06
2.05
1.7
2.6
u/ml
991.7
672.8
—
6
15
(3035637) Corticotropin [Mass/volume] in Plasma
6
15
4.06
2.05
1.0
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
39
250
1.64
2.05
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
119
1.91
2.03
19.6
7.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
91
703
1.41
1.99
3.5
3.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
21
3.38
1.97
1.0
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
144
1203
1.36
1.96
3.7
3.5
estimate
0.0
0.0
0.00
28
203
(3003327) Ova and parasites identified in Stool by Light microscopy
15
71
2.17
1.95
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
213
1.67
1.95
4.1
2.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
11
4.60
1.95
17.4
1.4
u/l
189.6
218.2
—
5
11
(3002385) Erythrocyte distribution width [Ratio]
231
2081
1.40
1.93
47.8
14.3
%
14.7
13.6
20.57
231
2038
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
19
100
1.96
1.90
1.4
1.9
—
151.4
—
0
7
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
12
4.21
1.83
3.4
1.1
—
—
—
0
0
(3015736) pH of Urine
117
955
1.36
1.82
3.0
3.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
524
1.43
1.82
6.0
3.8
ng/l
131.0
319.3
0.90
60
414
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
18
3.38
1.75
2.0
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
24
2.96
1.73
1.7
1.5
%
90.6
90.5
—
7
24
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
19
3.20
1.67
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
19
3.20
1.67
6.8
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
19
3.20
1.67
1.7
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
213
1916
1.34
1.64
4.1
3.7
pmol/l
15.1
14.8
0.66
205
1724
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
199
1.62
1.64
4.2
2.1
ml/min/173m2
57.2
64.5
0.75
21
81
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
170
1482
1.31
1.64
2.7
2.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
20
3.04
1.59
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
146
1.70
1.56
2.6
2.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
12
228
0.51
1.52
1.3
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
419
1.41
1.46
3.9
2.6
e6/l
1.5
1.2
0.34
37
232
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
16
3.16
1.44
1.0
1.4
ug/l
15.2
16.7
—
5
16
(3011397) Hemoglobin [Presence] in Urine by Test strip
72
567
1.35
1.38
3.3
3.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
97
1.79
1.38
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
81
657
1.31
1.27
4.1
3.7
estimate
0.0
0.0
0.50
25
199
(3023410) Appearance of Cerebral spinal fluid
6
25
2.43
1.25
5.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
41
300
1.42
1.22
2.1
2.3
ug/g
235.4
114.3
0.75
31
232
(3045414) Leukocytes [Presence] in Urine
17
101
1.72
1.22
1.9
1.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
37
2.19
1.22
2.4
2.3
mmol/l
106.0
105.0
—
8
37
(3041354) Potassium [Moles/volume] in Venous blood
8
37
2.19
1.22
2.4
2.3
mmol/l
4.0
4.1
—
8
37
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
37
2.19
1.22
2.4
2.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
(4268621)
6
26
2.33
1.19
2.0
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
50
2.03
1.17
1.2
1.2
—
—
—
0
0
(3013512) EKG study
91
763
1.27
1.11
3.8
3.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
81
1.76
1.11
2.5
3.4
mmol/l
4.0
3.9
0.11
14
75
(3016018) Differential panel - Cerebral spinal fluid
5
21
2.40
1.09
4.6
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
13
74
1.79
1.08
1.1
1.1
—
111.4
—
0
7
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
7
33
2.15
1.06
1.0
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
111
962
1.24
1.01
4.0
3.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
71
584
1.28
1.01
4.1
3.7
kg/l
1.0
1.0
2.44
14
88
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
65
529
1.29
1.00
1.5
1.7
pmol/l
508.0
13380717.6
0.50
52
426
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
23
2.19
0.98
1.2
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
23
2.19
0.98
2.0
2.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
20
133
1.54
0.97
2.6
2.2
%
0.6
0.7
0.21
20
133
(3044290) Cell count panel - Cerebral spinal fluid
9
51
1.79
0.95
3.0
1.1
—
—
—
0
0
(4062490)
6
27
2.24
0.94
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
126
1.54
0.93
1.2
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
28
2.16
0.92
1.0
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
20
135
1.51
0.91
2.6
3.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
56
1.81
0.89
2.2
2.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
64
1.74
0.87
2.8
1.7
pmol/l
174.9
259.1
1.99
11
59
(3041096) Erythrocytes [Presence] in Urine by Automated
78
662
1.24
0.85
3.7
3.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
45
1.80
0.85
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
31
1.95
0.85
1.7
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
172
1.43
0.83
2.5
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
48
1.68
0.79
1.0
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
100
0.49
0.78
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
34
1.78
0.76
1.3
1.4
pmol/l
68.5
65.3
—
6
34
(3023511) Choriogonadotropin [Units/volume] in Urine
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
83
1.59
0.76
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
83
1.59
0.76
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
38
1.86
0.74
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
92
808
1.19
0.71
3.6
3.3
mg/l
3232.2
144.2
1.56
67
518
(3019832) Treponema pallidum Ab [Presence] in Serum
21
152
1.41
0.71
1.4
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
26
1.94
0.71
2.8
4.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
85
1.55
0.70
1.2
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
28
1.80
0.66
14.4
3.4
mmol/l
6.2
7.4
—
5
21
(3003740) Influenza virus B Ag [Presence] in Specimen
5
28
1.80
0.66
3.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
28
1.80
0.66
3.2
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
249
2389
1.19
0.62
31.8
10.8
ml/min/173m2
74.1
79.6
3.11
229
1916
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
30
1.68
0.61
2.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
30
1.68
0.61
1.4
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
220
0.71
0.61
1.7
1.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
20
0.00
0.60
0.0
1.3
—
4807.5
—
0
15
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
7
111
0.62
0.59
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
123
0.64
0.56
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
41
343
1.22
0.53
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
180
1700
1.13
0.51
3.4
3.1
u/l
61.5
47.8
0.85
170
1591
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
155
0.70
0.49
1.0
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
42
356
1.21
0.49
23.1
24.6
inr
1.2
1.3
—
6
55
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
241
2324
1.15
0.48
5.1
4.5
mu/l
1.9
2.4
0.53
232
2110
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
255
2473
1.16
0.45
5.0
4.1
mmol/l
1.6
1.3
1.51
246
2263
(3049717) Cytology report of Urine Cyto stain
11
78
1.42
0.43
3.6
1.8
—
—
—
0
0
(4034850)
6
93
0.64
0.43
8.2
7.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
87
1.39
0.43
2.3
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
279
2847
0.84
0.42
55.2
17.8
e9/l
8.1
6.7
0.79
274
2762
(1761868) Lipid panel - Serum or Plasma
84
920
0.88
0.42
3.3
3.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
33
1.52
0.41
1.4
1.2
—
1.2
—
0
11
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
33
1.52
0.41
1.0
1.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
279
2846
0.84
0.41
55.1
17.8
e12/l
4.0
4.5
28.68
274
2760
(3020491) Glucose [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.8
—
7.7
—
0
13
(3020891) Body temperature
14
106
1.34
0.40
4.5
4.0
—
—
—
0
0
(4010399)
15
192
0.77
0.39
1.7
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
338
1.18
0.37
10.7
6.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
93
858
1.12
0.37
4.3
4.0
mg/mmol
19.7
8.7
0.80
61
549
(40761511) CBC panel - Blood by Automated count
261
2668
0.88
0.35
28.6
11.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
669
1.12
0.33
1.7
1.7
mmol/l
2.1
1.4
1.06
65
555
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
176
0.79
0.33
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
47
1.28
0.32
1.2
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
21
174
1.22
0.32
1.6
1.3
—
36.2
—
0
10
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
35
307
1.16
0.30
1.5
1.8
%
1.4
1.6
0.70
28
277
(4094501)
11
84
1.32
0.30
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
55
1.28
0.30
2.4
2.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
195
0.81
0.29
1.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
73
786
0.91
0.28
3.6
3.5
%
23.8
24.4
0.14
37
345
(1761482) Bacteria [#/volume] in Urine by Culture
9
74
1.22
0.25
3.8
4.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
50
546
0.90
0.25
2.4
2.5
ug/l
0.7
0.7
0.01
31
352
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
82
0.73
0.24
1.3
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.23
2.3
2.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
90
851
1.08
0.22
3.5
3.2
mmol/l
8.2
7.8
0.38
77
713
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.2
—
243.2
—
0
6
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(4015189)
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
11.8
—
0.6
—
0
12
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
9.1
—
0
12
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
4.0
—
32.0
—
0
8
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
453
1.10
0.20
1.2
1.3
u/ml
1.3
12.7
3.13
17
170
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
51
1.18
0.19
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
50
464
1.09
0.19
1.2
1.3
iu/ml
17.1
33.3
1.65
16
146
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
195
0.86
0.18
1.5
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
259
2625
0.93
0.17
5.7
5.1
mmol/l
2.5
2.7
4.81
251
2420
(3039443) Prostate specific Ag panel - Serum or Plasma
8
71
1.13
0.16
2.0
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
2.0
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
203
0.88
0.15
1.5
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
182
0.87
0.15
1.4
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
284
0.91
0.14
1.7
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
250
2526
0.95
0.10
5.4
4.6
mmol/l
6.1
6.0
0.83
236
2294
(3028707) Methadone [Presence] in Urine by Screen method
5
44
1.14
0.10
1.0
2.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
64
1.10
0.08
1.1
1.2
—
2.9
—
0
6
(3016879) Cocaine [Presence] in Urine
8
76
1.05
0.07
1.0
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
77
1.04
0.07
1.0
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
78
1.03
0.07
1.0
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
21
197
1.07
0.06
3.0
2.5
—
8.0
—
0
7
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
100
984
1.02
0.04
4.2
3.7
ug/l
7.4
1.9
0.48
92
879
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
41
399
1.03
0.03
1.7
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
92
1.09
0.03
2.0
2.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
243
2419
1.02
0.02
6.3
6.1
mmol/mol
39.1
40.3
1.67
231
2256
(3009542) Hematocrit [Volume Fraction] of Blood
231
2319
0.99
0.01
38.8
13.0
%
36.9
40.4
5.77
153
1629
(3000492) Spirometry study
23
223
1.03
0.01
2.1
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
302
0.99
0.00
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
257
2571
1.00
0.00
5.4
4.6
mmol/l
4.3
4.6
4.64
252
2377
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
255
2553
0.99
0.00
5.2
4.5
mmol/l
1.3
1.5
6.73
247
2351
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
53
533
0.99
0.00
1.2
1.2
u/ml
1.0
1.8
—
9
142
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
156
1.03
0.00
1.2
1.3
iu/ml
30.7
118.3
—
6
63
(3011288) Drugs identified in Urine by Screen method
5
55
0.91
0.00
1.2
3.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.2
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.6
—
5.8
—
0
9
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
79
1.01
0.00
1.0
2.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
1378.4
—
0
9
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
76
0.92
0.00
1.1
1.2
—
9.8
—
0
12
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
74
0.94
0.00
1.1
1.3
—
2.6
—
0
12
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
52
0.96
0.00
1.0
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
62
0.97
0.00
1.0
2.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
367.8
—
0
6
(3027008) Opiates [Presence] in Urine
8
79
1.01
0.00
1.0
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
21.9
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
69
1.01
0.00
1.1
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
65
0.92
0.00
1.0
1.2
—
42.1
—
0
7
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
68
0.88
0.00
1.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_CML_EXALLC – Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).